Sturamustine

Sturamustine, also known as dehydroepiandrosterone (DHEA) 17β-"N"-(2-chloroethyl)-"N"-nitrosourea, is a synthetic androstane steroid and a C17β nitrosourea conjugate of dehydroepiandrosterone (DHEA) which was developed as a cytostatic antineoplastic agent (i.e., a chemotherapy drug) for the treatment of hormone-dependent tumors but was never marketed. It was synthesized in 1982.